Jinyang County is a county of Sichuan Province, China. It is under the administration of the Liangshan Yi Autonomous Prefecture.

During the past decade, Jin Yang conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jin Yang" are "HER2+ Breast Cancer" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "Jin Yang" in a lesser frequency.

Most popular intervention types in "Jin Yang" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pyrotinib" (2 trials), "AI" (1 trials), "Anti-PD-1 monoclonal antibody" (1 trials), "CDK4/6 inhibitor" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jin Yang" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Jin Yang". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jin Yang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jin Yang, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".